Search results
Results from the WOW.Com Content Network
A 10-mg oral capsule of dicyclomine hydrochloride. Dicycloverine was first synthesized chemically in the United States circa 1945 by scientists at William S. Merrell Company. [12] It was first marketed in 1952 for gastrointestinal disorders, including colic in infants. [9] The INN name "dicycloverine" was recommended in 1959. [13]
SS Cap Arcona, named after Cape Arkona on the island of Rügen, was a large German ocean liner, later a requisitioned auxiliary ship of the Kriegsmarine (Nazi German War Navy), and finally a prison ship in the later months of World War II (1939–1945).
Atomoxetine is sometimes used in the treatment of cognitive impairment and frontal lobe symptoms due to conditions like traumatic brain injury (TBI). [47] [48] It is used to treat ADHD-like symptoms such as sustained attentional problems, disinhibition, [49] lack of arousal, fatigue, and depression, including symptoms from cognitive disengagement syndrome. [47]
In the United States and Canada, clorazepate is available in 3.75, 7.5, and 15 mg capsules or tablets. In Europe, tablet formations are 5 mg, 10 mg, 20 mg and 50 mg. [6] Clorazepate SD (controlled release) is available and may have a reduced incidence of adverse effects. The sustained-release formulation of clorazepate has some advantages in ...
One of the latest encourages people to follow a 10-3-2-1-0 sleep rule, which is actually not just one thing you do before you hit the hay. It's a series of pre-bedtime steps you take throughout ...
Damtew appeared in Washington, DC federal court on Tuesday, Dec. 10 where he was released. He faces a potential maximum sentence of 20 years in prison and a maximum fine of $250,000.
The Nicaraguan parliament, dominated by the ruling Sandinista Front, on Friday approved a constitutional reform that hands more power to President Daniel Ortega as well as the Central American ...
It remained available in Italy under the brand name Parmodalin (10 mg of tranylcypromine and 1 mg of trifluoperazine) until its discontinuation in 2019. Likewise, a combination with amobarbital (potent sedative/hypnotic agent) for the amelioration of psychoneurosis and insomnia existed under the brand name Jalonac.